Top-Rated StocksTop-RatedTop MarketRank™ StocksTop MarketRank™Top-Rated Dividend StocksTop-Rated DividendNYSE:MET MetLife (MET) Stock Price, News & Analysis $99.46 +1.13 (+1.15%) As of 10:28 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About MetLife Stock (NYSE:MET) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MetLife alerts:Sign Up Key Stats Today's Range$98.88▼$99.6850-Day Range$93.55▼$100.0652-Week Range$67.33▼$100.93Volume179,519 shsAverage Volume3.62 million shsMarket Capitalization$64.00 billionP/E Ratio19.06Dividend Yield2.38%Price Target$106.69Consensus RatingBuy Company Overview MetLife, Inc. is a global financial services company that provides insurance, employee benefits and retirement solutions. Its products and services include life insurance, dental and vision coverage, disability insurance, accident and health benefits, annuities, and savings and retirement products. The company serves individuals, employers and institutions through group benefits, workplace solutions and individual insurance offerings. MetLife also provides investment and retirement services designed to help employers and employees prepare for long-term financial needs. Founded in 1868, MetLife is headquartered in New York City and operates through businesses in the United States and international markets, including regions across Latin America, Asia and Europe. Its distribution channels include employers, financial professionals, brokers and other business partners.AI Generated. May Contain Errors. Read More MetLife Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks99th Percentile Overall ScoreMET MarketRank™: MetLife scored higher than 99% of companies evaluated by MarketBeat, and ranked 31st out of 851 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingBuy Consensus RatingMetLife has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 12 buy ratings, no hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for MetLife is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageMetLife has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about MetLife's stock forecast and price target. Earnings and Valuation3.8 / 5Proj. Earnings Growth8.30% Earnings GrowthEarnings for MetLife are expected to grow by 8.30% in the coming year, from $9.88 to $10.70 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MetLife is 19.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.05.Price to Earnings Ratio vs. SectorThe P/E ratio of MetLife is 19.04, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 24.75.Price to Earnings Growth RatioMetLife has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioMetLife has a P/B Ratio of 2.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about MetLife's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.75% of the float of MetLife has been sold short.Short Interest Ratio / Days to CoverMetLife has a short interest ratio ("days to cover") of 3.33, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MetLife has recently decreased by 8.82%, indicating that investor sentiment is improving significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldMetLife pays a meaningful dividend of 2.41%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMetLife has been increasing its dividend for 12 years.Dividend CoverageThe dividend payout ratio of MetLife is 45.40%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, MetLife will have a dividend payout ratio of 22.15% next year. This indicates that MetLife will be able to sustain or increase its dividend.Read more about MetLife's dividend. News and Social Media3.5 / 5News Sentiment0.59 News SentimentMetLife has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.News Coverage This WeekMarketBeat has tracked 17 news articles for MetLife this week, compared to 8 articles on an average week.Search Interest7 people have searched for MET on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.MarketBeat Follows13 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is an increase of 160% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, MetLife insiders have not sold or bought any company stock.Percentage Held by Insiders0.40% of the stock of MetLife is held by insiders.Percentage Held by Institutions94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MetLife's insider trading history. Receive MET Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MetLife and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MET Stock News HeadlinesMetLife (NYSE:MET) versus Palomar (NASDAQ:PLMR) Critical ComparisonOctober 10 at 2:15 AM | americanbankingnews.comKalshi launches probe into bets on Trump's pick for White House Press Secretary, according to WSJOctober 9 at 10:25 PM | msn.comElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men described the same moment in strikingly similar terms: a technological tipping point they call the Singularity. James Altucher says the idea once belonged to science fiction. Now he connects it to a move Musk could make as soon as October 21, and lays out what both men see coming in a short presentation.October 12 at 1:00 AM | Paradigm Press (Ad)Metlife Fixed Rate Preferreds: Strong Yield But With High Interest Rate ExposureOctober 9 at 7:23 AM | seekingalpha.comMetLife to Announce Third Quarter 2026 ResultsOctober 7, 2026 | businesswire.com5 Insurance Stocks Built to Keep Paying Dividends Through Hurricanes and Market CrashesOctober 7, 2026 | 247wallst.comA Record 95% of Sponsors With De-Risking Goals Intend to Fully Divest Their Pension Liabilities, MetLife Poll FindsOctober 7, 2026 | finance.yahoo.comMetLife, Inc. (NYSE:MET) Shareholders Set to Receive $0.59 Quarterly DividendOctober 7, 2026 | americanbankingnews.comSee More Headlines MET Stock Analysis - Frequently Asked Questions How have MET shares performed this year? MetLife's stock was trading at $78.98 at the beginning of the year. Since then, MET shares have increased by 25.9% and is now trading at $99.4230. How were MetLife's earnings last quarter? MetLife, Inc. (NYSE:MET) posted its quarterly earnings results on Wednesday, August, 5th. The financial services provider reported $2.43 earnings per share for the quarter, topping analysts' consensus estimates of $2.30 by $0.13. MetLife's revenue for the quarter was up 10.5% compared to the same quarter last year. Read the conference call transcript. Is MetLife doing a stock buyback? MetLife's board initiated a share buyback plan on Wednesday, August 5th 2026, which permits the company to repurchase $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 4.9% of its stock through open market purchases. Stock buyback plans are often a sign that the company's management believes its shares are undervalued. Does MetLife have any subsidiaries? MetLife subsidiaries include these companies: Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and more. Who are MetLife's major shareholders? Top institutional shareholders of MetLife include Valley Wealth Managers Inc. (0.05%), Ferguson Wellman Capital Management Inc. (0.03%), Argent Capital Management LLC (0.02%) and Farther Finance Advisors LLC (0.01%). Insiders that own company stock include Ramy Tadros and Bill Pappas. View institutional ownership trends. How do I buy shares of MetLife? Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MetLife own? Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), ExxonMobil (XOM), Salesforce (CRM) and Verizon Communications (VZ). Company Calendar Record date for 9/8 Dividend8/04/2026Ex-Dividend for 9/8 Dividend8/04/2026Last Earnings8/05/2026Dividend Payable9/08/2026Today10/12/2026Record date for 12/8 Dividend11/03/2026Ex-Dividend for 12/8 Dividend11/03/2026Next Earnings (Estimated)11/04/2026Dividend Payable12/08/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 MET's financial health is in the Green zone, according to TradeSmith. MET has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Insurance Sub-IndustryLife & Health Insurance Current SymbolNYSE:MET CIK1099219 Webwww.metlife.com Phone(212) 578-9500Fax212-578-3320Employees46,000Year Founded1868Price Target and Rating Average Price Target for MetLife$106.69 High Price Target$111.00 Low Price Target$96.00 Potential Upside/Downside+7.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)$5.22 Trailing P/E Ratio19.01 Forward P/E Ratio10.04 P/E Growth0.93Net Income$3.38 billion Net Margins4.57% Pretax Margin6.13% Return on Equity23.39% Return on Assets0.89% Debt Debt-to-Equity Ratio0.52 Current Ratio0.20 Quick Ratio0.20 Sales & Book Value Annual Sales$77.73 billion Price / Sales0.82 Cash Flow$7.82 per share Price / Cash Flow12.69 Book Value$43.53 per share Price / Book2.28Miscellaneous Outstanding Shares643,437,000Free Float640,863,000Market Cap$63.83 billion OptionableOptionable Beta0.78 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NYSE:MET) was last updated on 10/12/2026 by MarketBeat.com Staff. From Our PartnersTrump To Relaunch USD?President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may b...Porter & Company | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredFree Ticker: Anthropic's silent partner could soar after record $2 trillion IPOAnthropic's IPO prospectus just leaked, revealing 261 pages tied to a record $2 trillion valuation. Beyond ...Monument Traders Alliance | SponsoredUrgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20thMarc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...Chaikin Analytics | SponsoredGold did this exact thing in 1975… [then exploded]In 1975 the Fed raised rates and gold fell 50 percent. Headlines called the gold bull market dead. Instead gol...Golden Portfolio | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MetLife, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MetLife With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
